1	Enhanced	Enhance	B-NP	VBN	O	2	NMOD
2	virulence	virulence	I-NP	NN	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	Chlamydia	Chlamydia	B-NP	NN	O	7	NMOD
5	muridarum	muridarum	I-NP	NN	O	7	NMOD
6	respiratory	respiratory	I-NP	JJ	O	7	NMOD
7	infections	infection	I-NP	NNS	O	3	PMOD
8	in	in	B-PP	IN	O	2	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	absence	absence	I-NP	NN	O	8	PMOD
11	of	of	B-PP	IN	O	10	NMOD
12	TLR2	TLR2	B-NP	NN	B-protein	13	NMOD
13	activation	activation	I-NP	NN	O	11	PMOD
14	.	.	O	.	O	2	P

1	Chlamydia	Chlamydia	B-NP	NN	O	2	NMOD
2	trachomatis	trachomatis	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	a	a	B-NP	DT	O	8	NMOD
5	common	common	I-NP	JJ	O	7	AMOD
6	sexually	sexually	I-NP	RB	O	7	AMOD
7	transmitted	transmit	I-NP	VBN	O	8	NMOD
8	pathogen	pathogen	I-NP	NN	O	3	PRD
9	and	and	O	CC	O	3	VMOD
10	is	be	B-VP	VBZ	O	3	VMOD
11	associated	associate	I-VP	VBN	O	10	VC
12	with	with	B-PP	IN	O	11	VMOD
13	infant	infant	B-NP	NN	O	14	NMOD
14	pneumonia	pneumonia	I-NP	NN	O	12	PMOD
15	.	.	O	.	O	3	P

1	Data	Datum	B-NP	NNS	O	12	SUB
2	from	from	B-PP	IN	O	1	NMOD
3	the	the	B-NP	DT	O	6	NMOD
4	female	female	I-NP	JJ	O	6	NMOD
5	mouse	mouse	I-NP	NN	O	6	NMOD
6	model	model	I-NP	NN	O	2	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	genital	genital	B-NP	JJ	O	11	NMOD
9	tract	tract	I-NP	NN	O	11	NMOD
10	chlamydia	chlamydia	I-NP	NN	O	11	NMOD
11	infection	infection	I-NP	NN	O	7	PMOD
12	suggests	suggest	B-VP	VBZ	O	0	ROOT
13	a	a	B-NP	DT	O	14	NMOD
14	requirement	requirement	I-NP	NN	O	12	OBJ
15	for	for	B-PP	IN	O	14	NMOD
16	TLR2-dependent	TLR2-dependent	B-NP	JJ	O	17	NMOD
17	signaling	signaling	I-NP	NN	O	15	PMOD
18	in	in	B-PP	IN	O	17	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	induction	induction	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	inflammation	inflammation	B-NP	NN	O	25	NMOD
23	and	and	I-NP	CC	O	25	NMOD
24	oviduct	oviduct	I-NP	NN	O	25	NMOD
25	pathology	pathology	I-NP	NN	O	21	PMOD
26	.	.	O	.	O	12	P

1	We	We	B-NP	PRP	O	2	SUB
2	hypothesized	hypothesize	B-VP	VBD	O	0	ROOT
3	that	that	B-SBAR	IN	O	2	VMOD
4	the	the	B-NP	DT	O	5	NMOD
5	role	role	I-NP	NN	O	12	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	TLR2	TLR2	B-NP	NN	B-protein	6	PMOD
8	in	in	B-PP	IN	O	5	NMOD
9	moderating	moderate	B-VP	VBG	O	8	PMOD
10	mucosal	mucosal	B-NP	JJ	O	11	NMOD
11	inflammation	inflammation	I-NP	NN	O	9	OBJ
12	is	be	B-VP	VBZ	O	3	SBAR
13	site	site	B-NP	NN	O	12	PRD
14	specific	specific	B-ADJP	JJ	O	13	AMOD
15	.	.	O	.	O	2	P

1	In	In	B-SBAR	IN	O	8	VMOD
2	order	order	O	NN	O	1	DEP
3	to	to	B-VP	TO	O	4	VMOD
4	investigate	investigate	I-VP	VB	O	1	SBAR
5	this	this	B-NP	DT	O	4	OBJ
6	,	,	O	,	O	8	P
7	we	we	B-NP	PRP	O	8	SUB
8	infected	infect	B-VP	VBD	O	0	ROOT
9	mice	mouse	B-NP	NNS	O	8	OBJ
10	via	via	B-PP	IN	O	8	VMOD
11	the	the	B-NP	DT	O	13	NMOD
12	intranasal	intranasal	I-NP	JJ	O	13	NMOD
13	route	route	I-NP	NN	O	10	PMOD
14	with	with	B-PP	IN	O	13	NMOD
15	C.	C.	B-NP	NN	O	16	NMOD
16	muridarum	muridarum	I-NP	NN	O	14	PMOD
17	and	and	O	CC	O	8	VMOD
18	observed	observe	B-VP	VBD	O	8	VMOD
19	that	that	B-SBAR	IN	O	18	VMOD
20	in	in	B-PP	IN	O	28	VMOD
21	the	the	B-NP	DT	O	22	NMOD
22	absence	absence	I-NP	NN	O	20	PMOD
23	of	of	B-PP	IN	O	22	NMOD
24	TLR2	TLR2	B-NP	NN	B-protein	25	NMOD
25	activation	activation	I-NP	NN	O	23	PMOD
26	,	,	O	,	O	28	P
27	mice	mouse	B-NP	NNS	O	28	SUB
28	had	have	B-VP	VBD	O	19	SBAR
29	more	more	B-NP	RBR	O	30	AMOD
30	severe	severe	I-NP	JJ	O	31	NMOD
31	disease	disease	I-NP	NN	O	28	OBJ
32	,	,	O	,	O	28	P
33	higher	high	B-NP	JJR	O	36	NMOD
34	lung	lung	I-NP	NN	B-protein	36	NMOD
35	cytokine	cytokine	I-NP	NN	I-protein	36	NMOD
36	levels	level	I-NP	NNS	O	28	OBJ
37	,	,	O	,	O	8	VMOD
38	and	and	O	CC	O	41	NMOD
39	an	an	B-NP	DT	O	41	NMOD
40	exaggerated	exaggerated	I-NP	JJ	O	41	NMOD
41	influx	influx	I-NP	NN	O	37	OBJ
42	of	of	B-PP	IN	O	41	NMOD
43	neutrophils	neutrophil	B-NP	NNS	B-cell_type	45	NMOD
44	and	and	I-NP	CC	O	45	NMOD
45	T-cells	T-cell	I-NP	NNS	B-cell_type	42	PMOD
46	into	into	B-PP	IN	O	41	NMOD
47	the	the	B-NP	DT	O	48	NMOD
48	lungs	lung	I-NP	NNS	O	46	PMOD
49	.	.	O	.	O	8	P

1	This	This	B-NP	DT	O	2	SUB
2	could	could	B-VP	MD	O	0	ROOT
3	not	not	I-VP	RB	O	2	VMOD
4	be	be	I-VP	VB	O	2	VC
5	explained	explain	I-VP	VBN	O	4	VC
6	by	by	B-PP	IN	O	5	VMOD
7	impaired	impaired	B-NP	JJ	O	8	AMOD
8	bacterial	bacterial	I-NP	JJ	O	9	NMOD
9	clearance	clearance	I-NP	NN	O	6	PMOD
10	as	as	B-PP	IN	O	9	NMOD
11	TLR2-deficient	TLR2-deficient	B-NP	JJ	O	12	NMOD
12	mice	mouse	I-NP	NNS	O	10	PMOD
13	cleared	clear	B-VP	VBD	O	2	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	infection	infection	I-NP	NN	O	13	OBJ
16	similar	similar	B-ADJP	JJ	O	15	NMOD
17	to	to	B-PP	TO	O	16	AMOD
18	controls	control	B-NP	NNS	O	17	PMOD
19	.	.	O	.	O	2	P

1	These	These	B-NP	DT	O	2	NMOD
2	data	datum	I-NP	NNS	O	3	SUB
3	suggest	suggest	B-VP	VBP	O	0	ROOT
4	that	that	B-SBAR	IN	O	18	DEP
5	TLR2	TLR2	B-NP	NN	B-protein	6	SUB
6	has	have	B-VP	VBZ	O	4	SBAR
7	an	an	B-NP	DT	O	9	NMOD
8	anti-inflammatory	anti-inflammatory	I-NP	JJ	O	9	NMOD
9	function	function	I-NP	NN	O	6	OBJ
10	in	in	B-PP	IN	O	6	VMOD
11	the	the	B-NP	DT	O	12	NMOD
12	lung	lung	I-NP	NN	O	10	PMOD
13	during	during	B-PP	IN	O	6	VMOD
14	Chlamydia	Chlamydia	B-NP	NN	O	15	NMOD
15	infection	infection	I-NP	NN	O	13	PMOD
16	,	,	O	,	O	18	P
17	and	and	O	CC	O	18	DEP
18	that	that	B-SBAR	IN	O	3	VMOD
19	the	the	B-NP	DT	O	20	NMOD
20	role	role	I-NP	NN	O	26	SUB
21	of	of	B-PP	IN	O	20	NMOD
22	TLR2	TLR2	B-NP	NN	B-protein	21	PMOD
23	in	in	B-PP	IN	O	20	NMOD
24	mucosal	mucosal	B-NP	JJ	O	25	NMOD
25	inflammation	inflammation	I-NP	NN	O	23	PMOD
26	varies	vary	B-VP	VBZ	O	18	SBAR
27	at	at	B-PP	IN	O	26	VMOD
28	different	different	B-NP	JJ	O	30	NMOD
29	mucosal	mucosal	I-NP	JJ	O	30	NMOD
30	surfaces	surface	I-NP	NNS	O	27	PMOD
31	.	.	O	.	O	3	P

